Abstract
Longstanding and therapy-resistant hypertension may cause cerebral, renal, cardiac and retinal end-organ damage (EOD). Retinal hypertensive abnormalities are correlated with an increased risk of cardiovascular (CV) disease in general but are not included in CV risk assessment tools. Research into prevalence and determinants of retinal organ damage, such as hypertensive retinopathy (HR), is scarce. We evaluated the prevalence of HR and the association with other signs of EOD in patients with hypertension. A retrospective observational study was performed in all hypertensive patients referred by a general practitioner to the hypertension clinic at the Diakonessenhuis, Utrecht and Zeist, the Netherlands between 2011 and 2013. A screening of risk factors, albuminuria, left-ventricular hypertrophy (LVH) and retinal fundoscopy was performed. In all, 44% (123/280) of patients referred to the clinic were diagnosed with HR, while 15 and 11% were diagnosed with LVH and microalbuminuria, respectively. Patients with isolated HR consisted of 31% of all patients. When HR was added as a form of EOD, the percentage of patients with a treatment indication increased from 3 to 14%. Patients who were already on treatment goal exhibited a high prevalence of HR (28%), warranting treatment intensification. HR is prevalent in a third of hypertensive patients referred to our clinic, and isolated HR accounts for the majority of (end-) organ damages. Fundoscopy in the evaluation of hypertension might improve the indication for therapy. Furthermore, diagnosing HR could be helpful in selecting patients with hypertension on treatment goal in need of more aggressive treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–838.
Muiesan ML, Salvetti M, Rizzoni D, Paini A, gabiti-Rosei C, Aggiusti C et al. Resistant hypertension and target organ damage. Hypertens Res 2013; 36: 485–491.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281–1357.
James PA, Oparil S, Carter BL, Cushman WC, nison-Himmelfarb C, Handler J et al. evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507–520.
Cooper LS, Wong TY, Klein R, Sharrett AR, Bryan RN, Hubbard LD et al. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke 2006; 37: 82–86.
Mimoun L, Massin P, Steg G . Retinal microvascularisation abnormalities and cardiovascular risk. Arch Cardiovasc Dis 2009; 102: 449–456.
Longstreth W Jr . Larsen EK, Klein R, Wong TY, Sharrett AR, Lefkowitz D et al. Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly: the Cardiovascular Health Study. Am J Epidemiol 2007; 165: 78–84.
Ong YT, Wong TY, Klein R, Klein BE, Mitchell P, Sharrett AR et al. Hypertensive retinopathy and risk of stroke. Hypertension 2013; 62: 706–711.
Sairenchi T, Iso H, Yamagishi K, Irie F, Okubo Y, Gunji J et al. Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study. Circulation 2011; 124: 2502–2511.
Suri MF, Qureshi AI . Hypertensive retinopathy and risk of cardiovascular diseases in a national cohort. J Vasc Interv Neurol 2008; 1: 75–78.
Duncan BB, Wong TY, Tyroler HA, Davis CE, Fuchs FD . Hypertensive retinopathy and incident coronary heart disease in high risk men. Br J Ophthalmol 2002; 86: 1002–1006.
Schouten EG, Vandenbroucke JP, van d H-W, van der Heide RM . Retinopathy as an independent indicator of all-causes mortality. Int J Epidemiol 1986; 15: 234–236.
Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De BG et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1–266.
Use of glycated haemoglobin (HbA1c in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation [webpage on the Internet]. Geneva: World Health Organization, 2011. Available from http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/Accessed.
Alberti KG, Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.
Keith NM, Wagener HP, Barker NW . Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1974; 268: 336–345.
Toto RD . Microalbuminuria: definition, detection, and clinical significance. J Clin Hypertens (Greenwich) 2004; 6: 2–7.
Sokolow M, Lyon TP . The ventricular complex in right ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 38: 273–294.
Figueiredo Neto JA, Palacio GL, Santos AN, Chaves PS, Gomes GV, Cabral TS . Direct ophthalmoscopy versus detection of hypertensive retinopathy: a comparative study. Arq Bras Cardiol 2010; 95: 215–221.
Helvaci MR, Ozcura F, Kaya H, Yalcin A . Funduscopic examination has limited benefit for management of hypertension. Int Heart J 2007; 48: 187–194.
Cuspidi C, Macca G, Salerno M, Michev L, Fusi V, Severgnini B et al. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination? Ital Heart J 2001; 2: 702–706.
Erden S, Bicakci E . Hypertensive retinopathy: incidence, risk factors, and comorbidities. Clin Exp Hypertens 2012; 34: 397–401.
Triantafyllou A, Anyfanti P, Zabulis X, Gavriilaki E, Karamaounas P, Gkaliagkousi E et al. Accumulation of microvascular target organ damage in newly diagnosed hypertensive patients. J Am Soc Hypertens 2014; 8: 542–549.
Gudmundsdottir H, Taarnhoj NC, Strand AH, Kjeldsen SE, Hoieggen A, Os I . Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men. J Hum Hypertens 2010; 24: 505–513.
Cugati S, Cikamatana L, Wang JJ, Kifley A, Liew G, Mitchell P . Five-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains Eye Study. Eye (Lond) 2006; 20: 1239–1245.
Biesenbach G, Zazgornik J . High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy. Clin Nephrol 1994; 41: 211–218.
Wang S, Xu L, Jonas JB, Wang YS, Wang YX, You QS et al. Five-year incidence of retinal microvascular abnormalities and associations with arterial hypertension: the Beijing Eye Study 2001/2006. Ophthalmology 2012; 119: 2592–2599.
Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K . Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. J Hypertens 1995; 13: 155–160.
Karaca M, Coban E, Ozdem S, Unal M, Salim O, Yucel O . The association between endothelial dysfunction and hypertensive retinopathy in essential hypertension. Med Sci Monit 2014; 20: 78–82.
Coban E, Nizam I, Topal C, Akar Y . The association of low-grade systemic inflammation with hypertensive retinopathy. Clin Exp Hypertens 2010; 32: 528–531.
Coban E, Alkan E, Altuntas S, Akar Y . Serum ferritin levels correlate with hypertensive retinopathy. Med Sci Monit 2010; 16: CR92–CR95.
Foguet Q, Rodriguez A, Saez M, Ubieto A, Beltran M, Barcelo MA et al. Usefulness of optic fundus examination with retinography in initial evaluation of hypertensive patients. Am J Hypertens 2008; 21: 400–405.
Joshi V, Agurto C, VanNess R, Nemeth S, Soliz P, Barriga S . Comprehensive automatic assessment of retinal vascular abnormalities for computer-assisted retinopathy grading. Conf Proc IEEE Eng Med Biol Soc 2014; 2014: 6320–6323.
Schuster AK, Fischer JE, Vossmerbaeumer C, Vossmerbaeumer U . Optical coherence tomography-based retinal vessel analysis for the evaluation of hypertensive vasculopathy. Acta Ophthalmol 2015; 93: e148–e153.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kolman, S., van Sijl, A., van der Sluijs, F. et al. Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension. J Hum Hypertens 31, 121–125 (2017). https://doi.org/10.1038/jhh.2016.49
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2016.49
This article is cited by
-
Hypertensive eye disease
Nature Reviews Disease Primers (2022)
-
The relationship between Subfoveal Choroidal Thickness and Hypertensive Retinopathy
Scientific Reports (2021)
-
Morphological changes in and quantitative analysis of macular retinal microvasculature by optical coherence tomography angiography in hypertensive retinopathy
Hypertension Research (2021)
-
Efficient hybrid approach to segment and classify exudates for DR prediction
Multimedia Tools and Applications (2020)